Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Daichi Fujimoto, M.D., Ph.D.

Concepts (90)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Daichi Fujimoto's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Daichi Fujimoto has written about over time.
Pneumocystis carinii, 1 publications between 2014 and 2014, average publication date May 2014. Brain Infarction, 1 publications between 2018 and 2018, average publication date November 2018. Bronchoalveolar Lavage Fluid, 2 publications between 2014 and 2024, average publication date June 2019. Catheter Ablation, 2 publications between 2018 and 2022, average publication date June 2020. Pneumonia, 1 publications between 2021 and 2021, average publication date April 2021. Cardiomyopathy, Hypertrophic, 1 publications between 2022 and 2022, average publication date May 2022. Coronary Artery Disease, 14 publications between 2022 and 2024, average publication date September 2023. Acute Coronary Syndrome, 5 publications between 2022 and 2024, average publication date October 2023. Coronary Vessels, 13 publications between 2022 and 2024, average publication date December 2023. Plaque, Atherosclerotic, 11 publications between 2022 and 2024, average publication date December 2023. Tomography, Optical Coherence, 14 publications between 2022 and 2024, average publication date December 2023. Coronary Angiography, 14 publications between 2022 and 2024, average publication date December 2023.

To see the data from this visualization as text, click here.
Fujimoto's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (90)
Explore
_
Co-Authors (7)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.